2.24
1.82%
0.04
Pre-mercato:
2.20
-0.04
-1.79%
Precedente Chiudi:
$2.20
Aprire:
$2.19
Volume 24 ore:
527.85K
Relative Volume:
0.71
Capitalizzazione di mercato:
$126.75M
Reddito:
-
Utile/perdita netta:
$-82.44M
Rapporto P/E:
-1.1915
EPS:
-1.88
Flusso di cassa netto:
$-66.75M
1 W Prestazione:
-0.44%
1M Prestazione:
+0.90%
6M Prestazione:
-61.04%
1 anno Prestazione:
-18.84%
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Nome
Black Diamond Therapeutics Inc
Settore
Industria
Telefono
617-417-5868
Indirizzo
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Confronta BDTX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.24 | 126.75M | 0 | -82.44M | -66.75M | -1.88 |
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-07-31 | Iniziato | Raymond James | Outperform |
2023-07-14 | Iniziato | Piper Sandler | Overweight |
2023-06-30 | Aggiornamento | Stifel | Hold → Buy |
2023-06-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2023-06-27 | Aggiornamento | Wedbush | Neutral → Outperform |
2022-03-29 | Downgrade | Wedbush | Outperform → Neutral |
2022-03-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
2021-09-30 | Iniziato | Stifel | Hold |
2021-01-07 | Iniziato | Wedbush | Outperform |
2020-11-24 | Iniziato | Berenberg | Buy |
2020-05-04 | Iniziato | H.C. Wainwright | Buy |
2020-02-24 | Iniziato | Canaccord Genuity | Buy |
2020-02-24 | Iniziato | Cowen | Outperform |
2020-02-24 | Iniziato | JP Morgan | Overweight |
2020-02-24 | Iniziato | Jefferies | Buy |
Mostra tutto
Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie
Barclays PLC Has $339,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Critical Comparison: Black Diamond Therapeutics (NASDAQ:BDTX) & Cardiol Therapeutics (NASDAQ:CRDL) - Defense World
3 US Penny Stocks With Market Caps Under $200M - Simply Wall St
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - Benzinga
Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year? - Yahoo Finance
BDTX stock touches 52-week low at $2.08 amid market challenges - Investing.com
BDTX stock touches 52-week low at $2.08 amid market challenges By Investing.com - Investing.com South Africa
Roche purchases shares in tender offer for Poseida Therapeutics, Inc. - Yahoo Finance
Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven? - Yahoo Finance
XORTX Adds Late Stage Gout Program to Pipeline - Yahoo Finance
Geode Capital Management LLC Raises Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Geode Capital Management LLC Grows Stock Holdings in BARK, Inc. (NYSE:BARK) - Defense World
Barclays PLC Acquires 11,273 Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World
Geode Capital Management LLC Buys 50,579 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) - Defense World
Barclays PLC Has $339,000 Stock Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now? - Yahoo Finance
State Street Corp Buys 118,764 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics: Speculative Buy With Precision Oncology Catalysts (BDTX) - Seeking Alpha
Barclays PLC Has $1.10 Million Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World
Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance
Analysts Expect Breakeven For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Before Long - Yahoo Finance
Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025? - Yahoo Finance
Is Sarepta Therapeutics, Inc. (SRPT) the Best Performing Biotech Stock in 2024? - Yahoo Finance
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week - Yahoo Finance
Charles Schwab Investment Management Inc. Boosts Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BDTX stock touches 52-week low at $2.31 amid market challenges - Investing.com India
Analytical Overview: Black Diamond Therapeutics Inc (BDTX)’s Ratios Tell a Financial Story - The Dwinnex
Fmr LLC Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Akava Therapeutics, Inc. congratulates SAB Chair Dr. Hande Ozdinler, Founder Dr. Richard B. Silverman, and Dr. William Klein on their recent grant of $7.3 million from the National Institute on Aging to investigate AKV9 in neurodegenerative diseases - Yahoo Finance
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance
US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks - Simply Wall St
Black Diamond (BDTX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Fmr LLC Decreases Stock Position in Mobileye Global Inc. (NASDAQ:MBLY) - Defense World
MFA Financial, Inc. (NYSE:MFA) Shares Sold by Fmr LLC - Defense World
BNP Paribas Financial Markets Purchases 111,027 Shares of Under Armour, Inc. (NYSE:UA) - Defense World
Fmr LLC Has $15.49 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
MetLife Investment Management LLC Raises Stake in Smith-Midland Co. (NASDAQ:SMID) - Defense World
BNP Paribas Financial Markets Raises Stake in RadNet, Inc. (NASDAQ:RDNT) - Defense World
Fmr LLC Increases Position in AppFolio, Inc. (NASDAQ:APPF) - Defense World
Fmr LLC Raises Stock Position in ADT Inc. (NYSE:ADT) - Defense World
Charles Schwab Investment Management Inc. Sells 309,336 Shares of Unisys Co. (NYSE:UIS) - Defense World
Oruka Therapeutics, Inc. (NASDAQ:ORKA) institutional investors have had a good week as stock gains 15% - Yahoo Finance
Point72 Asset Management L.P. Takes $3.03 Million Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) has caught the attention of institutional investors who hold a sizeable 42% stake - Yahoo Finance
The number of Black Fortune 500 CEOs is still abysmally low. A ‘shocking’ corporate DEI practice might be to blame, Stanford professor says - Yahoo Finance
vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference - Yahoo Finance
Vestal Point Capital LP Purchases 2,928,500 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - MarketBeat
Gene and Cell Therapies Targeting CNS Disorders Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - The Globe and Mail
Gene and Cell Therapies Targeting CNS Disorders Treatment - openPR
Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Yahoo Finance
Black Diamond Therapeutics Inc Azioni (BDTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):